INTRODUCTION www.food.actapol.net/ successfully establish itself in the intestinal tract and prevent multiplication and even decrease the number of putrefactive bacteria. Certain strains of Lactobacillus were isolated and found to be capable of colonizing human digestive tract by Minoru Shirota, Japan in 1930. Scientists have continued to investigate possible benefi ts of bacteria to human health [Vasiljevic and Shah 2008] .
SOURCES AND DESCRIPTIONS OF PROBIOTICS
Probiotics are microorganisms which confer health benefi ts upon application in suffi ciently-high viable cell amounts. Probiotics are commonly associated with human gastrointestinal tracts [Weinbreck et al. 2010] . Some of the descriptions and defi nitions of probiotics commonly cited over the years in Table 1 [ Vasiljevic and Shah 2008] .
Species belonging to Bifi dobacterium and Lactobacillus are largely used as probiotics. They are also divided two groups as intestinal and vaginal sources [Goktepe et al. 2006] .
Bifi dobacteria are an important group of probiotic cultures commonly used in fermented dairy products. Bifi dobacterium are Gram positive, anaerobic, non motile and non-sporulating organisms. They may have various shapes such as short curved rods, club shaped rods, and bifurcated Y shaped rods [Prasanna et al. 2014] . The species included in the genus Bifi dobacterium are 29: B. adolescentis, B. angulatum, B. animalis, B. asteroides, B. bifi dum, B. boum, B. breve, B. catenulatum, B. choerinum, B. coryneforme, B. cuniculi, B. dentium, B. gallicum, B. gallinarum, B. indicum, B. longum, B. magnum, B. merycicum, B. minimum, B. pseudocatenulatum, B. pseudolongum, B. psychraerophilum, B. pullorum, B. ruminantium, B. saeculare, [Lee and Salminen 2009] . The effectiveness of this organism is related to its ability to colonize the intestinal tract and control undesirable intestinal bacteria. The optimum pH for the growth of Bifi dobacteria is 6.0-7.0 and virtually no growth at below of 4.5 or above of 8.5. The optimum temperatures of growth are 37-41°C, the minimum are 25-28°C, and the maximum are 43-45°C. Some Bifidobacterium cultures used as probiotic are B. adolescentis, B. longum, B. infantis, and B. breve [Rivera--Espinoza and Gallardo-Navarro 2010] .
Lactic acid bacteria -LAB are usually described as Gram-positive microorganisms, devoid of cytochromes and preferring anaerobic conditions but are aerotolerant, fastidious, acid-tolerant, and strictly fermentative [Lee and Salminen 2009] . At present, more than 125 Lactobacillus species have been identifi ed [Sungsoo Cho and Finocchiaro 2010; Table 2 ]. The most important genera are: Lactobacillus, Lactococcus, Enterocococcus, Streptococcus, Pediococcus, Leuconostoc, and Bifi dobacterium. However, Bifi dobacterium shares certain physiological and biochemical properties with typical. Therefore, for practical and traditional reasons, bifi dobacteria are still considered a part of the LAB group. Members of the LAB are usually subdivided into two distinct groups based on their carbohydrate metabolism: the homofermentative group which produce lactic acid as principal metabolite and the heterofermentative group which also [Vasiljevic and Shah 2008] . The growth of L. acidophilus occurs at a temperature as high as 45°C; however, the optimum is found between 35 and 40°C. The organisms grow in slightly acidic media at pH of 6.4-4.5, but growth will stop at a pH of 4.0-3.6. This bacterium tolerates from 0.3% to 1.9% titrable acidity, with and optimum pH at 5.5-6.0 [Rivera-Espinoza and Gallardo-Navarro 2010].
L. rhamnosus is a LAB with probiotic capacity. The growth activity of LAB is affected by fermentation conditions such as pH, temperature, medium composition and other factors [Pimentel-González et al. 2009] .
Probiotic microorganisms are mostly of GIT origin. Microbial population are changeable throughout the GIT (Table 3) , to 10 1 to 10 3 ·ml -1 (or g -1 ) in the stomach, 10 7 ml -1 in the jejunum (comprising mainly lactobacilli, Enterobacteriaceae and streptococci), up to 10 9 CFU·g -1 in the terminal ileum, and ca. 5·10 11 g -1 in the distal colon [Goktepe et al. 2006] . LAB, especially strains of Lactobacillus, are normally found in the human adult gastrointestinal (GI) tract, and have Bifi dobacterium spp. www.food.actapol.net/ been prevalently used as probiotics, exclusively in fermented dairy products [Tulumoglu et al. 2013] . Probiotic microorganisms are mostly of human or animal origin. The dairy industry, in particular, has found probiotic cultures. Yoghurts and fermented milks are the main vehicles for probiotic cultures [Trabelsi et al. 2013] . New products such as milk-based desserts, powdered milk for newborn infants, icecreams, butter, mayonnaise, various types of cheese are also being introduced in the international market [Cruz et al. 2009] ; however, some studies show that strains recognised as probiotics are also found in non-dairy fermented substrates [Martins et al. 2013] . Fermentation has been used to preserve, improve the [Martins et al. 2013] . These products can be in the form of capsules or powders to be dissolved in cold drinks, and fermented foods of vegetable origin [Cruz et al. 2009 ].
HEALTH BENEFITS
Over the last 20 years there has been an increased interest in the role of probiotic bacteria in human health [Chandramouli et al. 2004 ]. Probiotics are defi ned as live microbial feed supplements [Okuro et al. 2013 ] which benefi cially affect the host by improving the intestinal microbial balance [Kima et al. 2008] . Several health benefi ts are attributed to the ingestion of foods containing probiotic cultures. Some of them proved scientifi cally and others still requiring further studies in humans [Cruz et al. 2009 ].
Some of the major benefi ts of probiotics are: they reduce or eliminate ailments such as colon irritation, constipation and travellers diarrhoea [Rehaiem et al. 2014] . Other health benefi ts include inhibition of pathogenic bacteria, synthesis of B vitamins, lowering of blood ammonia levels, cholesterol absorption, inhibition of tumour formation [Capela et al. 2006] , improving the absorption of calcium [Shi et al. 2013] , and improvement of lactose utilization by producing b-galactosidase [Kima et al. 2008] , when there are enough probiotics in colon. In order to provide health benefi ts, it is essential that there is a minimum of one million viable probiotic organisms per gram of a product [Capela et al. 2006] , or 10 7 CFU·g -1 at point of delivery [Amine et al. 2014 , Li et al. 2011 , Semyonov et al. 2011 , or be eaten in suffi cient amounts to yield a daily intake of 10 8 CFU [Chávarri et al. 2010] , although the numbers vary from strain to strain [Anekella and Orsat 2013] .
Many studies have reported that probiotics are very sensitive to adverse environments, and survival rates of probiotics are poor in products. Due to their vast applications in food industries, it is urgent to develop new methods to preserve the viability of probiotics [Shi et al. 2013] .
Multiple reports have shown their health benefi ts on gastrointestinal infections, antimicrobial activity, improvement in lactose metabolism, reduction in serum cholesterol, immune system stimulation, antimutagenic properties, anti-carcinogenic properties, anti-diarrheal properties, improvement in infl ammatory bowel disease and suppression of Helicobacter pylori infection by addition of selected strains to food products [Pereira et al. 2011] .
The health benefi ts cannot be predicted for a determined species of microorganisms, and there is no single probiotic strain capable of providing all the benefi ts mentioned [Cruz et al. 2009 ].
ENCAPSULATIONS
Encapsulation may be defi ned as a process of entrapping one substance (active agent) within another substance (wall material). The substance that is encapsulating is often called the coating, membrane, shell, capsule, carrier material, external phase, or matrix [Nedovic et al. 2011] . The encapsulation technology has been used by the food industry for several years. The number of food compounds has been increasing, for example: fl avours, dyes, stabilizers, antioxidants, enzymes, probiotics, lipids, mineral salts and vitamins, among others [Estevinho et al. 2013] .
Microencapsulation in which the cells are retained within an encapsulating matrix or membrane [Pimentel-González et al. 2009 ], has emerged as an alternative for protection of probiotics, providing a particular and convenient micro-environment for the encapsulated microorganism, enhancing their viability, and enabling controlled release of cells in the intestinal tract. Encapsulation technology has been proved to be one of the most effective ways to protect probiotics during processing and subsequent storage. Furthermore, encapsulation systems with control-released ability can deliver probiotics to a specifi c target and release them at required time [Shi et al. 2013] . The benefi ts of encapsulation protect probiotics against stress conditions. Non-encapsulated probiotic microorganisms may be exposed to high temperatures, low pH, high osmotic pressure and high levels of oxygen during processing and storage of foods [Kailasapathy 2006 ]. The survival of probiotic organisms is also affected by acid in the stomach and the bile salts in the intestine tract [Capela et al. 2006] . These microcapsules may provide a more suitable anaerobic environment for the susceptible probiotic bacteria [Antunes et al. 2013 , Nag et al. 2011 , as well as protecting from bacteriophage and harsh enviroment [Heidebach et al. 2009 , Jiménez-Colmenero 2013 , Makinen et al. 2012 ], such as freezing and gastric conditions [Pimentel-González et al. 2009 ] thus reducing cell injury [Antunes et al. 2013] .
The capsules should also be able to maintain their entirety through the gastrointestinal tract until they reach colon, where they should comminute and release the probiotic bacteria. Probiotics have been shown liquid based products such as dairy products, while the effect of encapsulation on probiotic survival in dry (low water activity) food products is lower. While it is known that proteins and fats/waxes are good oxygen and moisture barriers, respectively, it is presently not understood whether these compounds are adequate to protect probiotics against these physical factors in dry food matrices. Therefore, protein-and fat-based encapsulates of a commonly used probiotic strain were prepared and the survival of these encapsulates during exposure to different water activities and oxygen levels were compared [Weinbreck et al. 2010] .
The functional performance of the microcapsules depends on the morphology, the chemical nature and the surface characteristics of the polymeric shell infl uenced by the process parameters [Butstraen and Salaün 2014] . A microcapsule consists of a semipermeable or non-permeable, spherical, thin and strong membrane surrounding a solid/liquid core, with a diameter varying from a few microns to 1 mm [Pimentel-González et al. 2009 ].
Encapsulation materials, Generally Recognized as Safe (GRAS) ingredients, can be used in food applications [Matalanis et al. 2011 , Shi et al. 2013 . Natural polymer based materials are preferred due to their biodegradability, compatibility food grade nature and wide availability [Antunes et al. 2013] . Xanthan gum, gellan gum, starch derivatives, cellulose acetate phthalate, casein, whey proteins [Nualkaekula et al. 2012] , chitosan, carboxymethyl cellulose, carrageenan, gelatin, pectin [Pimentel-González et al. 2009 ] vegetable gum, fats and alginate [Chávarri et al. 2010] can be used as encapsulation material. Alginate as an encapsulating agent is non-toxicity, simplicity in entrapping living microbial cells and low cost. Alginate is also an accepted food additive and can be safely used in foods. The use of alginate is limited due to its low stability in the presence of chelating agents and in acidic conditions below pH 2.0. The coating of alginate beads and its effectiveness in protecting probiotic bacteria has been extensively studied. Alginate microcapsules has been coasted with chitosan for improving activity [Chávarri et al. 2010] . The most commonly used gum is xanthan, a heteropolysaccharide consisting of polypentasaccharide groups formed from 2 glucose, 2 mannose and 1 glucuronic unit, with its polymer backbone consisting of 1→4 linked β-(D)-glucose units. Microcapsules were produced by the emulsion method in which the discrete water phase, containing xanthan gum was cross-linked with calcium chloride while suspended in oil. This property is advantageous in bacterial applications as the conditions are gentle enough not to damage the bacteria [Cook et al. 2012] . Casein, a milk protein, has been used in a few cases as a water insoluble (below pH 6) matrix for protecting bacteria during gastric transit. Milk proteins are particularly popular as encapsulating materials, while non-milk based materials are less desirable. Skimmedmilk has been utilised in microencapsulation by using rennet to gel the proteins contained in the milk [Cook et al. 2012] .
Encapsulating probiotics within a physical barrier has been investigated by many researchers. Encapsulation is considered as a technology of incorporating protective materials into small capsules that can be released at the controlled rate under specifi c conditions [Chávarri et al. 2010 , Shi et al. 2013 . The most used techniques to encapsulate probiotics are extrusion, atomisation or spray drying, emulsion, coacervation and immobilisation in fat and starch granules [Pedroso et al. 2012] . Many encapsulation technologies have been reported extrusion, emulsion method and spray drying technology. Extrusion method probably is the mildest one among all of probiotics encapsulation technologies. These method involves www.food.actapol.net/ dropping hydrocolloid solution with concentrated probiotics into solidifying solution [Shi et al. 2013 ]. In the emulsion method, a small volume of the cellpolymer suspension is added to a large volume of a vegetable oil such as soybean oil, sunfl ower oil, canola oil or corn oil. The mixture is homogenized to form a water-in-oil emulsion [Krasaekoopt et al. 2003 ]. Spray drying is a commonly used microencapsulation technique for probiotic encapsulation [Okuro et al. 2013] . This method involves atomization of an emulsion or a suspension of probiotics and encapsulating agents in a hot air drying chamber, resulting in rapid evaporation of water [Fritzen-Freire et al. 2013] .
RECENT ENCAPSULATED DEVELOPMENTS
Microencapsulation is substantial for the survival of probiotics during storage and their transit through the digestive tract. Probiotics must be encapsulated because they are very sensitive to environmental conditions such as air, moisture, temperature, stomach pH and bile salt solutions. Addition of microcapsules should not affect the sensory properties of food products [Burgain et al. 2011] .
L. bulgaricus was encapsulated in alginate-milk microspheres prepared by Shi et al. [2013] . The tolerance of encapsulated L. bulgaricus to adverse environments such as low pH (pH 2.0 and 2.5), high concentration of bile salt (1.0% and 2.0%) and long time storage (1 month), was investigated. This study showed that encapsulation could improve the tolerance of L. bulgaricus to adverse environments. However, alginate can provide limited protection to probiotics because alginate microspheres are not stable in acidic environment and have porous structure which allow diffusion of acid in and out of microspheres easily. Trabelsi et al. [2013] studied to develop the microencapsulation of a L. plantarum TN8 on sodium alginate. The optimal conditions identifi ed were 2% for sodium alginate, 10 10 CFU·ml -1 for biomass, and 30 min for hardening time. When the survival rates of free and microencapsulated L. plantarum TN8 during exposure to artifi cial gastrointestinal conditions were compared, the encapsulated cells exhibited signifi cantly higher resistances to artifi cial intestinal juice and artifi cial gastric juice. Annan et al. [2008] produced to encapsulate the probiotic B. adolescentis 15703T with alginate-coated gelatin microspheres. The alginate coated gelatin microspheres in simulated gastric juice (pH 2.0, 2 h) survive higher numbers due to the buffering effect of intact microspheres. Heidebach et al. [2010] produced casein-based microcapsules for coating two probiotic strains, which differ in their sensitivity against dehydration, L. F19 and B. Bb12 during freeze-drying. L. F19 survived in signifi cantly higher numbers in the encapsulated state, compared to free cells (proteincell-mixture) . Encapsulation improved the survival of B. Bb12 during storage for up to 90 days under all tested conditions. Kim et al. [2008] microencapsulated L. acidophilus ATCC 43121 with sodium alginate. They studied about the effects of microencapsulation on the changes in survival rate of the L. acidophilus ATCC 43121 during exposure to artifi cial gastrointestinal and on the change in heat susceptibility of L. acidophilus ATCC 43121 during the heat treatment. In addition, cholesterol assimilation and intestinal adhesion of non-encapsulated and encapsulated L. acidophilus ATCC 43121 were also investigated to explore the effect of microencapsulation on health benefi cial effect of lactic acid bacteria. Therefore, non-encapsulated cells were completely destroyed when exposed to artifi cial gastric juice (AGJ) of pH 1.2 and 1.5, while the treatment diminished the viable count of encapsulated samples only by 3 log. Encapsulated cells exhibited a signifi cantly higher resistance to artifi cial intestinal juice (AIJ) and heat treatment than nonencapsulated samples. However, encapsulation did not signifi cantly affect the adherence of L. acidophilus ATCC 43121 onto the human intestinal epithelial cell lines HT-29. The microencapsulation effectively protected the microorganisms from heat and acid treatment in delivering the viable cells to intestine without any signifi cant adverse effect on their functionalities. Chávarri et al. [2010] used chitosan as a coating material to improve encapsulation of L. gasseri (L) and B. bifi dum (B) in calcium alginate beads and the prebiotic quercetin (Q) with the objective of enhancing survival of the probiotic bacteria was used. These results indicated that the survival of microspheres with quercetin during storage at 4°C was possible, while probiotic bacteria microencapsulated with 413-424. www.food.actapol.net/ quercetin did not survive. Because of this, quercetin and L. gasseri or B. bifi dum were microencapsulated separately. Microencapsulated L. gasseri and microencapsulated B. bifi dum were resistant to simulated gastric conditions (pH 2.0, 2 h) and bile solution (3%, 2 h). Consequently, the microencapsulation of L. gasseri and B. bifi dum with alginate and a chitosan offered effective media for the microencapsulation of L. gasseri and B. bifi dum to the colon and maintaining their survival during simulated gastric and intestinal juice.
L. casei ATCC 393 was encapsulated with alginate, chitosan and carboxymethyl chitosan with extrusion method by Li et al. [2011] . Results indicated that alginate-chitosan-carboxymethyl chitosan microcapsules could successfully protect L. casei against negative conditions.
Probiotic organisms are typically added either to fresh foods with high water activities and an expected shelf-life of weeks (e.g. yogurt) or to dry products with low water activities (a w < 0.25) and an expected shelf-life of months (e.g. infant formula). For dry products, losses in probiotic viability cause considerable reductions in product shelf-life times [Weinbreck et al. 2010] .
Microencapsulated probiotic powder formulation provides a more convenient delivery format compared to wet gelled formulations. Fritzen-Freire et al. [2013] evaluate the viability and the physical properties of BB-12 microencapsulated by spray drying, as encapsulating agent, with the prebiotics inulin, oligofructose, and oligofructose-enriched inulin (at a ratio of 1:1, 200 g/L total concentrations). These microcapsules showed a high survival rate of bifi dobacteria during storage at the temperatures evaluated. Ying et al. [2013] were encapsulated L. rhamnosus GG (LGG) with spray drying. Then, capsules were added into apple juice or citrate buffer (pH 3.5) and stored at 4 or 25°C over a 5-week period. The LGG was encapsulated by using whey protein isolate (WPI) alone, WPI in combination with a physically-modifi ed resistant starch (RS) at various ratios (4:1, 1:1 and 1:4), or RS alone. Spray dried microencapsulated LGG formulated with WPI or WPI-RS mixtures protected LGG in low pH environments (pH 3.5 apple juice and citrate buffer) over 5 weeks storage at 4°C and were more effective than at high temperature storage (25°C). Microencapsulated LGG formulations containing WPI or WPI in combination with RS provided better protection to LGG in apple juice and citrate buffer solution than the formulation containing only RS under all storage conditions. Anekella and Orsat [2013] aimed to microencapsulate a combination of L. acidophilus NRRL B-4495 and L. rhamnosus NRRL B-442 in raspberry juice through spray drying. Role of maltodextrin as a carbon source was also assessed for its prebiotic potential. High temperatures during spray drying are harmful to probiotics and can be damaged by sub-lethal thermal shock. Increasing the microencapsulating material concentration increased the survival rate of the probiotics. Non-dairy probiotic foods are becoming popular as they do not pose problems of lactose intolerance.
Most of the products containing probiotic cells have been made to identify new food carriers (Table 5 ) [Burgain et al. 2011] .
Probiotics represent a fast developing fi eld. In past years, probiotics have expanded from the traditional health benefi t areas of digestive comfort and immune protection to diverse applications in various, sometimes unexpected, health benefi t areas. The use of microencapsulation to enhance the survival rates of probiotic microorganisms in connection with an application in food can be considered to be promising. These methods were optimized towards specifi c requirements. Many researchers have investigated strategies to improve the storage stability of encapsulated probiotics. Different foods containing encapsulated probiotic cells are present on the market. Belgium group Barry Callebaut produces chocolate containing encapsulated probiotic cells. In some cases, inulin or other prebiotics have been added to probiotics in the manufacturing of the bar called 'Attune', into yoghurt-covered raisins, nutrient bars, chocolate bars, or tablets. Unilever, Hansen, and company Dos Pinos, have developed a probiotic ice cream having multiple health benefi ts. Many products containing encapsulated probiotic cells are available in a tablet/capsule form or in a powder form. In conclusion, probiotic market has a strong future as the consumers demand is increasing.
